|
|
||||||||
CUTTING EDGE |

*
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, Madrid, Spain; and
Departamento de Biología Celular, Facultad de Biología, Universidad Complutense, Madrid, Spain
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Up to now, nearly 50 chemokines have been described. Trying to dissect the chemoattractant properties of so many similar proteins, a very active field of research has been, and still is, the identification of their receptor binding specificity. Indeed, binding preferences have already been established for most chemokines. Nevertheless, the receptors for some CC chemokines such as NCC-4 (6), pulmonary- and activation-regulating chemokine (7), or TECK (8) are not known yet. Similarly, some putative CC chemokine receptors like STRL33/Bonzo (9), CKRX/HCR (10), and GPR-9-6 (EMBL accession number U45982) remain orphan. We have analyzed the phylogenetic relationships between CC chemokine receptors and orphan receptors. Our data indicate the existence of a separate group the members of which are CCR6, CCR7, STRL33/Bonzo, and GPR-9-6. Besides their structural similarities, CCR6, CCR7, and STRL33/Bonzo also share an expression pattern that is mainly restricted to lymphoid organs (9, 11, 12). Data on the expression of GPR-9-6 were not available. Here we report that the CC chemokine TECK is a specific ligand for GPR-9-6. We have also cloned the mGPR-9-6 cDNA and found that it is activated by the murine version of TECK. In addition, the constitutive RNA expression of both genes in tissues, cell lines, and thymocyte subpopulations is also reported. Following current rules for chemokine receptor nomenclature, we propose to designate GPR-9-6 as CCR9.
| Materials and Methods |
|---|
|
|
|---|
Chemokines were purchased from Peprotech, Rocky Hill, NJ, or R&D Systems, Minneapolis, MN. The HEK 293 and MOLT4 cell lines were obtained from the American Type Culture Collection, Manassas, VA. Human and mGPR-9-6 cDNAs were cloned in pCIneo (Promega, Madison, WI), and stable transfectants were obtained after G418 selection of cells transfected with the resulting plasmids by the calcium phosphate method, as described (13). Thymocytes were purified from 57-wk-old female BALB/c mice using a FACSort cytometer (Becton Dickinson, Mountain View, CA) as described (14). Briefly, double-positive thymocytes were sorted as CD4+ CD8+ cells. CD4+ single-positive thymocytes were sorted as CD4+ cells after depletion of CD8+ thymocytes. CD8+ single-positive thymocytes were sorted as CD8+ cells. Pre-T cells were sorted as CD4-CD8- CD25+ cells after depletion of CD4+ and CD8+ thymocytes. After reanalysis, the sorted cell populations had a purity of >98%. The effect of pertussis or cholera toxins on the TECK-mediated GPR-9-6 signaling was analyzed by performing the assays on cells cultured for 16 h in 0.1 µg/ml pertussis toxin or 0.4 µg/ml cholera toxin.
Sequencing of mGPR-9-6
Based on the hGPR-9-6 sequence, a pair of oligonucleotides was designed (5'-AARTTYCARACITTYATGTGYAA-3' and 5'-GTRTGIATIATIATIGTRTARCARCA-3') and assayed in PCR amplifications using 129/SvJ mouse genomic DNA as template. A DNA fragment with the expected size was produced, and the sequencing of this material showed an open reading frame with a translated sequence that was 82% identical with that of the corresponding hGPR-9-6 sequence. Then, specific oligonucleotides were designed and used for 5'- and 3'-RACE of adapted murine thymus cDNA (Marathon cDNA amplification kit, Clontech Laboratories, Palo Alto, CA). DNA fragments corresponding to both the 5' and 3' mGPR-9-6 ends were obtained and sequenced. Finally, a DNA fragment containing the complete mGPR-9-6 coding sequence was synthesized by PCR from murine thymus cDNA.
Analysis of gene expression
Multiple tissue Northern blots (Clontech) were probed with a 32P-labeled 1120-bp DNA fragment containing most of the hGPR-9-6 coding sequence, as recommended by the supplier. Total RNA samples from mouse tissues or FACS-sorted cell subsets were extracted with Tri-reagent (Sigma Chemical, St. Louis, MO). RNA from tissues was electrophoresed on a denaturing formaldehyde-agarose gel and blotted onto nylon Hybond membranes. Prehybridization of the membranes and hybridization with a 32P-labeled DNA fragment containing the coding sequence of mGPR-9-6 were conducted in Rapid Hyb buffer (Amersham, Arlington Heights, IL) as recommended by the supplier. For RT-PCR analysis, total RNA from FACS-sorted cell subpopulations was reverse-transcribed as described (14). Equal amounts of cDNA were subjected to PCR amplification of mGPR-9-6 using specific forward (5'-ACGTGCTAGCCGCCATGATGCCCACAGAACTC-3') and reverse (5'-TGACCTTCAGGATCAAGACAGC-3') primers under the following conditions: 15 s at 94°C; 15 s at 59°C; 45 s at 72°C.
Calcium mobilization and chemotaxis studies
Calcium fluorometry on HEK 293 transfectant cells was conducted with indo-1-AM (Molecular Probes, Leiden, The Netherlands)-loaded cells as described (15). Each measure was done on 1-ml aliquots containing 3 x 106 cells. Additions of chemokines were done in 10 µl. Cell migration assays with stable HEK 293/hGPR-9-6 or HEK 293/pCIneo transfectants were performed in a 48-well microchamber (Neuro Probe, Cabin John, MD), as described (15).
| Results and Discussion |
|---|
|
|
|---|
and secondary
lymphoid-tissue chemokine, respectively, are also sequence related
(14). These facts prompted us to characterize in detail GPR-9-6, the
other member of this group of receptors for which the only information
available was the genomic sequence deposited in data banks.
|
We followed a 5'-RACE procedure on a human thymus
gt11 cDNA
library and found that the protein encoded by the GPR-9-6 mRNA was 12
amino acids longer than that encoded by the genomic coding sequence
previously reported. This indicates that an intron interrupts the
N-terminal coding sequence, as in CCR6 and CCR7. Recently, the sequence
of the region encompassing hGPR-9-6 gene has been reported (EMBL
accession number AC005669). Comparison of this sequence with that of
the hGPR-9-6 mRNA we report here revealed the presence of at least
three exons in the hGPR-9-6 gene (Fig. 1
B).
A degenerate PCR procedure with oligonucleotides based on the human
sequence, combined with 5'- and 3'-RACE allowed us to clone the murine
homologue of GPR-9-6 from mouse thymus cDNA. Sequencing of the PCR
products obtained detected an open reading frame the predicted amino
acid sequence of which was 86% identical with that of hGPR-9-6.
Particularly, the 78 C-terminal residues are the same in both species;
this identity is unique in the chemokine receptor family. Fig. 1
C shows the alignment of the predicted 369 amino acid
sequences of both hGPR-9-6 and mGPR-9-6 proteins. N32 is a potential
site for N-glycosylation in both polypeptides; N388 is an
additional potential site present only in the murine protein.
Analysis of hGPR-9-6 and mGPR-9-6 expression
Tissue distribution of hGPR-9-6 and mGPR-9-6 was studied by
Northern blot analysis of human poly(A)+ RNA or mouse total
RNA samples (Fig. 2
). Both genes showed a
high expression level in thymus; weak mRNA expression in spleen and
lymph nodes was also detected. Transcript sizes were 2.7 kb for
hGPR-9-6 and 3.3 kb for mGPR-9-6. Among several cell lines tested only
MOLT4 showed expression of hGPR-9-6 (Fig. 2
A). Because
thymus was the tissue showing maximal expression of mGPR-9-6, an RT-PCR
approach was used to analyze the expression of this gene in FACS-sorted
thymocyte subpopulations. Murine GPR-9-6 expression was found in
CD25+CD4-CD8- pre-T cells,
CD4+CD8+ immature thymocytes, as well as in
single positive CD4+ and CD8+ T cells (Fig. 2
C).
|
The ligand specificity of hGPR-9-6 was investigated by monitoring
changes in the intracellular calcium concentration of HEK 293/hGPR-9-6
stable transfected cells (293/hGPR-9-6), after sequential addition of
samples of chemokines. Among 36 recombinant human chemokines tested
(Fig. 3
A), only TECK elicited
a response. The addition of 200 nM hTECK to 293/hGPR-9-6 cells resulted
in significant calcium flux (Fig. 3
B, upper panel), and the
cell response was correlated to the chemokine dose down to 20 nM. HEK
293/mGPR-9-6 transfectant cells were also stimulated to mobilize
intracellular calcium by mTECK (Fig. 3
B, middle panel).
Addition of a high concentration of hTECK to 293/hGPR-9-6 cells
resulted in complete desensitization to a second addition of the same
stimulus (Fig. 3
C, upper tracing). Both human and mouse TECK
were able to stimulate the human receptor in the transfectant cells,
and this resulted in desensitization to a subsequent stimulus with
hTECK (Fig. 3
C, lower tracing). This interspecies
cross-reactivity is consistent with the report by Vicari et al. (8) on
mTECK-induced migration of human THP-1 cells and with the high degree
of homology between the amino acid sequences of both receptors.
|
, a chemokine for which HEK 293 cells express an endogenous
receptor, was completely abolished by this toxin. Cholera toxin did not
affect the hTECK-induced calcium response of 293/hGPR-9-6 cells (not
shown). These results suggest that hGPR-9-6 is partially but not
exclusively coupled to the G
i class of G
subunits (17). A similar situation has also been described for other
chemokine receptors (14, 18, 19). The functionality of hGPR-9-6 upon
hTECK stimulation in HEK 293 transfectants was also confirmed by
chemotaxis assays (Fig. 3hTECK-induced calcium mobilization in MOLT4 cells
Northern analysis revealed that the MOLT4 cell line expresses
hGPR-9-6 RNA. This is consistent with the thymic origin of these
CD4+ lymphoblastic T cells. Indo-1-AM-loaded MOLT4 cells
showed a high increase of intracellular calcium after stimulation with
200 nM hTECK (Fig. 4
A). The
cell response was correlated to the chemokine dose. MOLT4 cells were
slightly more sensitive than the transfectants to low doses of the
chemokine, given that 6 nM hTECK induced a detectable response.
Pertussis toxin reduced but did not abolish the MOLT4 response to hTECK
(Fig. 4
B), while cholera toxin did not affect that response
(not shown). These results are essentially identical with those
obtained with the 293/hGPR-9-6 transfectants and suggest that
hTECK-induced stimulation of MOLT4 cells is mediated, mainly if not
exclusively, by hGPR-9-6.
|
and
secondary lymphoid-tissue chemokine, the ligands for CCR6 and CCR7,
respectively, sharing unique structural features, as the
Asp-Cys-Cys-Leu motif (14). Also interesting is the fact that CCR9 has
an intron interrupting its coding sequence, as is the case for CCR6 and
CCR7. The fact that both immature and mature thymocytes express mCCR9 suggests that this receptor might play a role during the whole process of thymocyte development. Because thymic dendritic cells are producers of TECK (8), the TECK-mediated chemoattraction might be a mechanism contributing to thymocyte confinement in the thymus until completion of their development. The identification of CCR9 as the functional receptor for TECK will help to unravel the important role these proteins seem to play in thymus.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Gabriel Márquez, Departamento de Inmunología y Oncología Centro Nacional de Biotecnología, Universidad Autónoma de Madrid, Cantoblanco, 28049-Madrid, Spain. E-mail address: ![]()
3 Abbreviations used in this paper: CCR, CC chemokine receptor; TECK, thymus-expressed chemokine; GPR, G-protein-coupled receptor; m, murine; h, human; SDF-1
, stromal cell-derived factor-1
; RACE, rapid amplification of cDNA end. ![]()
Received for publication February 1, 1999. Accepted for publication March 16, 1999.
| References |
|---|
|
|
|---|
/LD78
and chemotactic for T lymphocytes, but not for monocytes. J. Immunol. 159:1140.[Abstract]
. FEBS Lett. 440:188.[Medline]
. Biochem. Biophys. Res. Commun. 236:212.[Medline]
This article has been cited by other articles:
![]() |
M. Parmo-Cabanas, D. Garcia-Bernal, R. Garcia-Verdugo, L. Kremer, G. Marquez, and J. Teixido Intracellular signaling required for CCL25-stimulated T cell adhesion mediated by the integrin {alpha}4{beta}1 J. Leukoc. Biol., August 1, 2007; 82(2): 380 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Schwarz, A. Sambandam, I. Maillard, B. C. Harman, P. E. Love, and A. Bhandoola Selective Thymus Settling Regulated by Cytokine and Chemokine Receptors J. Immunol., February 15, 2007; 178(4): 2008 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Knoechel, J. Lohr, S. Zhu, L. Wong, D. Hu, L. Ausubel, and A. K. Abbas Functional and Molecular Comparison of Anergic and Regulatory T Lymphocytes. J. Immunol., June 1, 2006; 176(11): 6473 - 6483. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alejo, M. B. Ruiz-Arguello, Y. Ho, V. P. Smith, M. Saraiva, and A. Alcami A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus PNAS, April 11, 2006; 103(15): 5995 - 6000. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Garcia-Ojeda, S. Dejbakhsh-Jones, D. Chatterjea-Matthes, A. Mukhopadhyay, A. BitMansour, I. L. Weissman, J. M. Y. Brown, and S. Strober Stepwise Development of Committed Progenitors in the Bone Marrow That Generate Functional T Cells in the Absence of the Thymus J. Immunol., October 1, 2005; 175(7): 4363 - 4373. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Henson, R. Snelgrove, T. Hussell, D. J. Wells, and R. Aspinall An IL-7 Fusion Protein That Shows Increased Thymopoietic Ability J. Immunol., September 15, 2005; 175(6): 4112 - 4118. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Benz and C. C. Bleul A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision J. Exp. Med., July 5, 2005; 202(1): 21 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Singh, U. P. Singh, J. K. Stiles, W. E. Grizzle, and J. W. Lillard Jr. Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion Clin. Cancer Res., December 15, 2004; 10(24): 8743 - 8750. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qiuping, X. Jei, J. Youxin, J. Wei, L. Chun, W. Jin, W. Qun, L. Yan, H. Chunsong, Y. Mingzhen, et al. CC Chemokine Ligand 25 Enhances Resistance to Apoptosis in CD4+ T Cells from Patients with T-Cell Lineage Acute and Chronic Lymphocytic Leukemia by Means of Livin Activation Cancer Res., October 15, 2004; 64(20): 7579 - 7587. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ueda, K. Yang, S. J. Foster, M. Kondo, and G. Kelsoe Inflammation Controls B Lymphopoiesis by Regulating Chemokine CXCL12 Expression J. Exp. Med., January 5, 2004; 199(1): 47 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qiuping, L. Qun, H. Chunsong, Z. Xiaolian, H. Baojun, Y. Mingzhen, L. Chengming, H. Jinshen, G. Qingping, Z. Kejian, et al. Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia Cancer Res., October 1, 2003; 63(19): 6469 - 6477. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Onai, M. Kitabatake, Y.-y. Zhang, H. Ishikawa, S. Ishikawa, and K. Matsushima Pivotal role of CCL25 (TECK)-CCR9 in the formation of gut cryptopatches and consequent appearance of intestinal intraepithelial T lymphocytes Int. Immunol., July 1, 2002; 14(7): 687 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uehara, A. Grinberg, J. M. Farber, and P. E. Love A Role for CCR9 in T Lymphocyte Development and Migration J. Immunol., March 15, 2002; 168(6): 2811 - 2819. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uehara, K. Song, J. M. Farber, and P. E. Love Characterization of CCR9 Expression and CCL25/Thymus-Expressed Chemokine Responsiveness During T Cell Development: CD3highCD69+ Thymocytes and {gamma}{delta}TCR+ Thymocytes Preferentially Respond to CCL25 J. Immunol., January 1, 2002; 168(1): 134 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Wurbel, M. Malissen, D. Guy-Grand, E. Meffre, M. C. Nussenzweig, M. Richelme, A. Carrier, and B. Malissen Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gamma delta + gut intraepithelial lymphocytes Blood, November 1, 2001; 98(9): 2626 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Youn, Y. J. Kim, C. Mantel, K.-Y. Yu, and H. E. Broxmeyer Blocking of c-FLIPL-independent cycloheximide-induced apoptosis or Fas-mediated apoptosis by the CC chemokine receptor 9/TECK interaction Blood, August 15, 2001; 98(4): 925 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wilbanks, S. C. Zondlo, K. Murphy, S. Mak, D. Soler, P. Langdon, D. P. Andrew, L. Wu, and M. Briskin Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines J. Immunol., April 15, 2001; 166(8): 5145 - 5154. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Carramolino, A. Zaballos, L. Kremer, R. Villares, P. Martin, C. Ardavin, C. Martinez-A, and G. Marquez Expression of CCR9 {beta}-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8+ T cells from secondary lymphoid organs Blood, February 15, 2001; 97(4): 850 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Romagnani, F. Annunziato, E. Lazzeri, L. Cosmi, C. Beltrame, L. Lasagni, G. Galli, M. Francalanci, R. Manetti, F. Marra, et al. Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) {alpha}{beta}+CD8+ single-positive T cells, TCR{gamma}{delta}+ T cells, and natural killer-type cells in human thymus Blood, February 1, 2001; 97(3): 601 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Papadakis, J. Prehn, V. Nelson, L. Cheng, S. W. Binder, P. D. Ponath, D. P. Andrew, and S. R. Targan The Role of Thymus-Expressed Chemokine and Its Receptor CCR9 on Lymphocytes in the Regional Specialization of the Mucosal Immune System J. Immunol., November 1, 2000; 165(9): 5069 - 5076. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Krzysiek, E. A. Lefevre, J. Bernard, A. Foussat, P. Galanaud, F. Louache, and Y. Richard Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha /CCL20 in human B cells Blood, October 1, 2000; 96(7): 2338 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yang, Q. Chen, S. Stoll, X. Chen, O. M. Z. Howard, and J. J. Oppenheim Differential Regulation of Responsiveness to fMLP and C5a Upon Dendritic Cell Maturation: Correlation with Receptor Expression J. Immunol., September 1, 2000; 165(5): 2694 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Z. Howard, H. F. Dong, A.-K. Shirakawa, and J. J. Oppenheim LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8 Blood, August 1, 2000; 96(3): 840 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Annunziato, P. Romagnani, L. Cosmi, C. Beltrame, B. H. Steiner, E. Lazzeri, C. J. Raport, G. Galli, R. Manetti, C. Mavilia, et al. Macrophage-Derived Chemokine and EBI1-Ligand Chemokine Attract Human Thymocytes in Different Stage of Development and Are Produced by Distinct Subsets of Medullary Epithelial Cells: Possible Implications for Negative Selection J. Immunol., July 1, 2000; 165(1): 238 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Murdoch and A. Finn Chemokine receptors and their role in inflammation and infectious diseases Blood, May 15, 2000; 95(10): 3032 - 3043. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Scoggins, J. R. Taylor Jr., J. Patrie, A. B. van't Wout, H. Schuitemaker, and D. Camerini Pathogenesis of Primary R5 Human Immunodeficiency Virus Type 1 Clones in SCID-hu Mice J. Virol., April 1, 2000; 74(7): 3205 - 3216. [Abstract] [Full Text] |
||||
![]() |
D. I. Jarmin, M. Rits, D. Bota, N. P. Gerard, G. J. Graham, I. Clark-Lewis, and C. Gerard Cutting Edge: Identification of the Orphan Receptor G-Protein-Coupled Receptor 2 as CCR10, a Specific Receptor for the Chemokine ESkine J. Immunol., April 1, 2000; 164(7): 3460 - 3464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gosling, D. J. Dairaghi, Y. Wang, M. Hanley, D. Talbot, Z. Miao, and T. J. Schall Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK J. Immunol., March 15, 2000; 164(6): 2851 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Murphy, M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors Pharmacol. Rev., March 1, 2000; 52(1): 145 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Yu, K. W. C. Peden, M. B. Zaitseva, H. Golding, and J. M. Farber CCR9A and CCR9B: Two Receptors for the Chemokine CCL25/TECK/Ck{beta}-15 That Differ in Their Sensitivities to Ligand J. Immunol., February 1, 2000; 164(3): 1293 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Norment, L. Y. Bogatzki, B. N. Gantner, and M. J. Bevan Murine CCR9, a Chemokine Receptor for Thymus-Expressed Chemokine That Is Up-Regulated Following Pre-TCR Signaling J. Immunol., January 15, 2000; 164(2): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Zabel, W. W. Agace, J. J. Campbell, H. M. Heath, D. Parent, A. I. Roberts, E. C. Ebert, N. Kassam, S. Qin, M. Zovko, et al. Human G Protein-coupled Receptor GPR-9-6/CC Chemokine Receptor 9 Is Selectively Expressed on Intestinal Homing T Lymphocytes, Mucosal Lymphocytes, and Thymocytes and Is Required for Thymus-expressed Chemokine-mediated Chemotaxis J. Exp. Med., November 1, 1999; 190(9): 1241 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Youn, C. H. Kim, F. O. Smith, and H. E. Broxmeyer TECK, an Efficacious Chemoattractant for Human Thymocytes, Uses GPR-9-6/CCR9 as a Specific Receptor Blood, October 1, 1999; 94(7): 2533 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, H. Soto, E. R. Oldham, M. E. Buchanan, B. Homey, D. Catron, N. Jenkins, N. G. Copeland, D. J. Gilbert, N. Nguyen, et al. Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2) J. Biol. Chem., July 14, 2000; 275(29): 22313 - 22323. [Abstract] [Full Text] [PDF] |
||||
| ||||||||